维普中文期刊产品整合服务
36篇 您的检索式:作者名="Minig"
    题名 作者 年代 出处 被引量
1Different strategies of treatment for uterine cervical carcinoma stage ⅠB2-ⅡB显示文摘Uterine cervical cancer is the second most common gynecological malignancy. It is estimated that over 35% of tumors are diagnosed at locally advanced disease, stage ⅠB2-ⅡB with an estimated 5-year overall survival of 60%. During the last decades, the initial treatment for these women has been debated and largely varies through different countries. Thus, radical concurrent chemoradiation is the standard of care in United Sated and Canada, and neoadjuvant chemotherapy followed by radical surgery is the first line of treatment in some institutions of Europe, Asia and Latin America. Until today, there is no evidence of which strategy is better over the other. This article describe the evidence as well as the advantages and disadvantages of the main strategies of treatment for women affected by uterine cervical cancer stage ⅠB2-ⅡB.Lucas Minig María Guadalupe Patrono Nuria Romero Juan Francisco Rodríguez Moreno Jesús Garcia-Donas 2014World Journal of Clinical Oncology2014,5,2:46
2Role of manganese superoxide dismutase on growth and invasive properties of human estrogen- independent breast cancer cells显示文摘Kattan Z Minig V Leroy P 2008Breast Cancer Res Treat2008,108,20:1
3α- rhamnosyl-β-glucosidase-catalyzed reactions for analysis and biotransformations of plant-based foods显示文摘Minig M Mazzaferro L S Erra-Balsells R 2011Journal of Agricultural and Food Chemistry2011,59,11:1
4Surgical outcomes and complications of prophylactic salpingectomy at the time of benign hysterectomy in premenopausal women 显示文摘Minig L Chuang L Patrono MG 2015J Minim Invasive Gynecol2015,22,4:1
5Robotic approach for cervical cancer : comparison with laparotomy : a case control study 显示文摘Maggioni A Minig L Zanagnolo V 2009Gynecol Oncol2009,115,1:1
6Progestin intrauterine de-vice and GnRH analogue for uterus-sparing treatment of endome-trial precancers and well-differentiated early endometrial carcino-ma in young women显示文摘Minig L Franchi D Boveri S 2011Ann Oncol2011,22,3:1
7Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of' endometrial preeancers and well-differentiated early endometrial carcinoma in young women 显示文摘Minig L Franchi D Boveri S 2011Ann Oneol2011,22,3:1
8The effect of earlyversus delayed postcaesarean feeding on women ’ s satisfaction : arandomised controlled trial显示文摘Izbizky GH Minig L Sebastiani MA 2008BJOG2008,115,3:1
9The effect of early ver- sus delayed post - caesarean feeding on women' s satisfaction: A randomised controlled trial显示文摘Izbizky GH Minig L Sebastiani MA 2008BJOG2008,115,3:1
10Regulation ofthe high basal expression of the manganese superoxide dis-mutase gene in aggressive breast cancer cells显示文摘Ennen M Minig V Grandemange S 2011FreeRadic Biol Med2011,50,12:1
11Ovarian low-grade serous carcinoma:a comprehensive update显示文摘Diaz-Padilla I Malpica AL Minig L 0,,02:1
12Role of manganese superoxide dismutase on growth and invasive properties of human estrogen - independent breast cancer cells 显示文摘Kattan Z Minig V Leroy P 2008Breast Cancer Res Treat2008,108,2:1
13Pmgastin intrauterine device and GnRH analogue for uterus - sparing treatment of endometrial precancers and well - differentiated early endometrial carcinoma in young women 显示文摘Minig L Franchi D Boveri S 2011Ann Oneo12011,22,3:1
14Robotic approach for cervical cancer: comparison with laparotomy: a case control study 显示文摘Maggioni A Minig L Zanagnolo V 2009Gynecol Oncol2009,115,1:1
15Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women显示文摘Minig L Franchi D Boveri S 0,,03:1
16Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial pre- cancers and well-differentiated early endometrial carcinoma in young women显示文摘Minig L Franchi D Boveri S 2011Annals of Oncology2011,22,3:1
17Therapeutic management of epithelial ovarian cancer during pregnancy 显示文摘Minig L Otafio L Diaz-Padilla I 2013Clin Transl 0ncol2013,15,4:1
18Platinum -based neoadju-vant chemotherapy followed by radical surgery for cervical carcino-ma international federation of gynecology and obstetrics stage I B2-II B显示文摘Minig L Colombo N Zanagnolo V 2013Int J Gynecol Cancer2013,23,:1
19Selecting the best strategy of treatment in newly diagnosed advanced-stage ovarian cancer patients显示文摘Although it is assumed that the combination of chemotherapy and radical surgery should be indicated in all newly diagnosed advanced-stage ovarian cancer patients, one of the main raised questions is how to select the best strategy of initial treatment in this group of patients, neoadjuvant chemotherapy followed by interval debulking surgery or primary debulking surgery followed by adjuvant chemotherapy. The selection criteria to offer one strategy over the other as well as a stepwise patient selection for initial treatment are described. Selecting the best strategy of treatment in newly diagnosed advanced stage ovarian cancer patients is a multifactorial and multidisciplinary decision. Several factors should be taken into consideration:(1) the disease factor, related to the extension and localization of the disease as well as tumor biology;(2) the patient factor, associated with patient age, poor performance status, and co-morbidities; and(3) institutional infrastructure factor, related to the lack of prolonged operative time, an appropriate surgical armamentarium, as well as well-equipped intensive care units with well-trained personnel.Lucas Minig Cristina Zorrero Pablo Padilla Iserte Andres Poveda 2015World Journal of Methodology2015,5,4:1
20Surveillance procedures for patients for cervical carcinoma : a review of the literature 显示文摘Zanagnolo V Minig LA Gadducci A 2009Int J Gynecol Cancer2009,19,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费